bloating on tirzepatide Side Effects: How Zepbound & Mounjaro Affect Digestion 3 Tips to Cope With

Glycocalyx-targeted therapy ameliorates age-related arterial dysfunction

Should one take B12 deficiency boosts in injections or pills

Who decides that

- behavior change platform moving into GLP-1 - : Tatari (Philip) - put Ro's GLP-1 story on national TV, 50% weekly jump in new patients Hudson Media Co (Yesenia) - drove Hims & Hers to 280% YoY revenue growth Rain (Robin) - launched Calibrate to its biggest signup month ever Media by Mother (Kathy Richter) - ran Found's "Not for Every Body" across CTV, social, and audio Roveia Health (Harsh) - rebuilt TrimRX's Meta and Google creative, cut acquisition costs Lantern (Seth) - scaled Weekend Health from launch to $25MM ARR in 15 months Drip Digital Media (Alex) - scaled Eden with 337% revenue growth and 50% CPA reduction Webtopia (Tristram) - scaled Fella Health's paid social from 5 to 40 ads/month BENlabs (Peter) - pivoted Noom's creator campaigns to education-led, 90% LTV lift Creekside Marketing (Samuel) - rebuilt Join Piper's Google Ads with missing audiences - & : Novo Nordisk - makes Wegovy and Ozempic, the drugs that started the GLP-1 wave Eli Lilly and Company - makes Zepbound, the fastest-growing GLP-1 entrant If you're running GLP-1 paid, DM me

Read full article: #CVRM #WVE007 #WaveLifeSciences To view or add a comment, sign in ALERT NEWS: HISTORIC BREAKTHROUGH IN MASH MANAGEMENT Imagine a silent enemy affecting eighty percent of obese individuals and seventy percent of diabetics: MASH (Metabolic dysfunction-Associated Steatohepatitis)